Puzzle Medical Devices Inc. Wins TCT 2022 Shark Tank Innovation Competition
NEW YORK – September 27, 2022 – The Cardiovascular Research Foundation (CRF) is pleased to...
Search for Articles
Sep 27, 2022
Sep 27, 2022
Renovacor Announces Upcoming Presentation at Keystone Symposia’s Heart Failure: Mechanisms and Therapies Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision...
Sep 20, 2022
Rocket Pharmaceuticals to Acquire Renovacor, Extending Leadership in AAV-based Cardiac Gene Therapy
CRANBURY, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage, clinical biotechnology...
Sep 19, 2022
First-in-Human Study Finds Mechanical Circulatory Support and Renal Perfusion Success with the ModulHeart Device
September 19, 2022 — A first-in-human (FIH) study using the ModulHeart device (Puzzle Medical Devices Inc.) has demonstrated...
Sep 16, 2022
HAYA Therapeutics Appoints Brian C. Thomas, Ph.D., as Chairperson of the Board of Directors
LAUSANNE, Switzerland and SAN DIEGO – Sept. 15, 2022 -- HAYA Therapeutics, SA, a company...
Sep 20, 2022
RapidPulse Raises Additional Funding for Ischemic Stroke Therapies and Notes Promising Results
MIAMI, Sept. 13, 2022 /PRNewswire/ -- RapidPulse, Inc., a privately-held medical device company developing a...